Generate Biomedicines
Somerville
About Generate Biomedicines
Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines. It pioneers in the field of Generative Biology, a revolutionary approach to drug development that allows them to program protein-based modalities for the first time. Generate Biomedicines has proved that its machine-learning platform can generate new biological molecules with therapeutic value, accelerating the drug discovery process.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $50K – $100K
- Total funding: $693.0M
- Funding stage: IPO
- Last round: Series C (Dec 2024)
- Website: generatebiomedicines.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Medical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/generate-biomedicines-16206 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.